[Therapeutic principles in systemic lupus erythematosis with phospholipid syndrome].
Reshetniak
T M
TM
Alekberova
Z S
ZS
Nasonov
E L
EL
Nasonova
V A
VA
D000925:Anticoagulants / Q000627:therapeutic use*; D016736:Antiphospholipid Syndrome / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D016896:Treatment Outcome
D000925:Anticoagulants; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors
Printsipy lecheniia antifosfolipidnogo sindroma pri sistemnoĭ krasnoĭ volchanke.